Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration.
Linde L, Ørnbjerg LM, Rasmussen SH, Love TJ, Loft AG, Závada J, Vencovský J, Laas K, Nordstrom D, Sokka-Isler T, Gudbjornsson B, Gröndal G, Iannone F, Ramonda R, Hellamand P, Kristianslund EK, Kvien TK, Rodrigues AM, Santos MJ, Codreanu C, Rotar Z, Tomšič M, Castrejon I, Díaz-Gonzáles F, Di Giuseppe D, Ljung L, Nissen MJ, Ciurea A, Macfarlane GJ, Heddle M, Glintborg B, Østergaard M, Hetland ML. Linde L, et al. Among authors: castrejon i. Arthritis Res Ther. 2023 Oct 19;25(1):205. doi: 10.1186/s13075-023-03184-7. Arthritis Res Ther. 2023. PMID: 37858143 Free PMC article.
Gender biases in Spanish rheumatology: Perception and facts.
Delgado Beltrán C, Castrejón I, Hernández-Cruz B, García Vivar ML, García de Vicuña R, Romera Baures M, Carreira P, Naredo E, Reina D, Galindo M, Peralta C, Varas de Dios B, Carmona L. Delgado Beltrán C, et al. Among authors: castrejon i. Reumatol Clin (Engl Ed). 2023 Aug-Sep;19(7):392-401. doi: 10.1016/j.reumae.2023.02.007. Epub 2023 May 8. Reumatol Clin (Engl Ed). 2023. PMID: 37164884 Free article.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
Linde L, Ørnbjerg LM, Brahe CH, Wallman JK, Di Giuseppe D, Závada J, Castrejon I, Díaz-Gonzalez F, Rotar Z, Tomšič M, Glintborg B, Gudbjornsson B, Geirsson AJ, Michelsen B, Kristianslund EK, Santos MJ, Barcelos A, Nordström D, Eklund KK, Ciurea A, Nissen M, Akar S, Hyldstrup LH, Krogh NS, Hetland ML, Østergaard M. Linde L, et al. Among authors: castrejon i. Rheumatology (Oxford). 2023 Sep 20:kead494. doi: 10.1093/rheumatology/kead494. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37738257
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Christiansen SN, Horskjær Rasmussen S, Pons M, Michelsen B, Glintborg B, Gudbjornsson B, Grondal G, Vencovsky J, Loft AG, Rotar Z, Pirkmajer KP, Nissen MJ, Baranová J, Macfarlane GJ, Jones GT, Iannone F, Caporali R, Laas K, Vorobjov S, Giuseppe DD, Olofsson T, Provan SA, Fagerli KM, Castrejon I, Otero-Varela L, van de Sande M, van der Horst-Bruinsma I, Nordström D, Kuusalo L, Bernardes M, Hetland ML, Østergaard M, Midtbøll Ørnbjerg L. Christiansen SN, et al. Among authors: castrejon i. Semin Arthritis Rheum. 2024 Apr;65:152388. doi: 10.1016/j.semarthrit.2024.152388. Epub 2024 Jan 26. Semin Arthritis Rheum. 2024. PMID: 38301349 Free article.
Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.
Valero M, Sanchez-Piedra C, Freire M, Colazo M, Busquets N, Merino-Ibarra E, Rodriguez-Lozano C, Manrique S, Campos C, Sanchez-Alonso F, Castrejon I. Valero M, et al. Among authors: castrejon i. Arthritis Res Ther. 2023 Oct 25;25(1):210. doi: 10.1186/s13075-023-03194-5. Arthritis Res Ther. 2023. PMID: 37880797 Free PMC article. No abstract available.
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register.
Molina-Collada J, Alonso F, Otero L, Bohórquez C, Díaz Torné C, Pérez García C, Blanco Madrigal JM, Vela P, Álvaro-Gracia JM, Castrejón I; BIOBADASER group. Molina-Collada J, et al. Among authors: castrejon i. Semin Arthritis Rheum. 2024 Feb;64:152341. doi: 10.1016/j.semarthrit.2023.152341. Epub 2023 Dec 9. Semin Arthritis Rheum. 2024. PMID: 38128174
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis.
Exposito L, Sánchez-Piedra C, Vela-Casasempere P, Moreno-Ramos MJ, Campos C, Bohorquez C, Manero J, Calvo-Gutiérrez J, Rodríguez-Lozano C, Ruiz-Montesino D, Busquets N, García-González J, Castrejón I, Alonso F, Bustabad S, Díaz-González F. Exposito L, et al. Among authors: castrejon i. Eur J Clin Invest. 2024 Feb;54(2):e14095. doi: 10.1111/eci.14095. Epub 2023 Sep 16. Eur J Clin Invest. 2024. PMID: 37715584
121 results